Campbell Newman Asset Management »

Catalyst Pharmaceutical Partners shares owned by Campbell Newman Asset Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Campbell Newman Asset Management from 13F filings

Historical chart of Campbell Newman Asset Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Campbell Newman Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Campbell Newman Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.8M 88k 20.87
2024-09-30 $1.8M 88k 19.88
2024-06-30 $1.4M 90k 15.49
2024-03-31 $1.4M 90k 15.94

More positions owned by Campbell Newman Asset Management

Apple Common Stocks (AAPL)
Microsoft Corp. Common Stocks (MSFT)
Broadcom Common Stocks (AVGO)
Eli Lilly & Co. Common Stocks (LLY)
Analog Devices Common Stocks (ADI)
Mastercard Common Stocks (MA)
KLA Corp. Common Stocks (KLAC)
Visa, Inc. Class A Common Stocks (V)
Arthur J. Gallagher & Co. Common Stocks (AJG)
Stryker Corp. Common Stocks (SYK)
Lowe's Companies Common Stocks (LOW)
TE Connectivity Common Stocks (TEL)
Jacobs Solutions Common Stocks (J)
Intercontinental Exchange Common Stocks (ICE)
Emerson Electric Common Stocks (EMR)

View all positions for Campbell Newman Asset Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
Deerfield Management Company
State Street Corporation
Dimensional Fund Advisors
Pacer Advisors
Geode Capital Management
Renaissance Technologies
First Trust Advisors
Royce & Associates
Goldman Sachs Group
Northern Trust
Robeco Investment Management
T. Rowe Price Associates
Charles Schwab Investment Management

View all funds holding Catalyst Pharmaceutical Partners